Drugs in the GLP-1 category are now being seen in a different light beyond that of weight control, and their promise is fascinating.

The MAHA movement says they will restore trust in Federal health agencies that lost public support during the pandemic.

Obesity has become a global health crisis, with an estimated 16% of the world’s adult population classified as obese. The search for effective treatments is more urgent than ever.

The economic impact of Type 2 diabetes is staggering. The time for half-measures and incremental change is long past.